BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$255B |
| 2 |
Thermo Fisher Scientific
TMO
|
+$458M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$288M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 5 |
Advanced Micro Devices
AMD
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$622M |
| 2 |
Microsoft
MSFT
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 4 |
Amazon
AMZN
|
+$353M |
| 5 |
Diageo
DEO
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.42% |
| 2 | Financials | 6.29% |
| 3 | Healthcare | 5.84% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Babcock & Wilcox
BW
$1.55B
| $92.5K | ﹤0.01% |
+14,498
| New | +$108K |
|
|
PPLT
3527
abrdn Physical Platinum Shares ETF
PPLT
$2.04B
| $92.4K | ﹤0.01% |
11,560
| – | – |
|
|
SCU
3528
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $92.4K | ﹤0.01% |
+10,449
| New | +$96.7K |
|
3529
Establishment Labs
ESTA
$2.4B
| $92.2K | ﹤0.01% |
1,689
+847
| +101% | +$50.6K |
|
3530
Evolv Technologies
EVLV
$1.05B
| $92.1K | ﹤0.01% |
+43,434
| New | +$113K |
|
3531
Tilly's
TLYS
$122M
| $91.9K | ﹤0.01% |
13,285
+3,388
| +34% | +$25.7K |
|
3532
Foghorn Therapeutics
FHTX
$371M
| $91.9K | ﹤0.01% |
+10,707
| New | +$138K |
|
3533
Identive
INVE
$64.1M
| $91.6K | ﹤0.01% |
7,307
+2,428
| +50% | +$33.3K |
|
3534
Enel Chile
ENIC
$6.22B
| $91.5K | ﹤0.01% |
66,319
-642
| -1% | -$954 |
|
|
NPKI
3535
NPK International
NPKI
$1.21B
| $91.1K | ﹤0.01% |
36,160
-114,199
| -76% | -$336K |
|
3536
Nature's Sunshine
NATR
$267M
| $88.9K | ﹤0.01% |
10,791
+4,185
| +63% | +$41.6K |
|
|
THRX
3537
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $88.8K | ﹤0.01% |
+15,310
| New | +$108K |
|
3538
Lindblad Expeditions
LIND
$2.18B
| $88.7K | ﹤0.01% |
13,127
+4,106
| +46% | +$35.8K |
|
|
HTB
3539
HomeTrust Bancshares
HTB
$834M
| $88.7K | ﹤0.01% |
4,015
+370
| +10% | +$8.93K |
|
3540
Utah Medical Products
UTMD
$225M
| $88.7K | ﹤0.01% |
1,040
+261
| +34% | +$23K |
|
3541
Safe Bulkers
SB
$790M
| $88.7K | ﹤0.01% |
35,917
+17,218
| +92% | +$58.2K |
|
3542
OptimizeRx
OPRX
$163M
| $88.5K | ﹤0.01% |
5,975
+264
| +5% | +$5.22K |
|
|
AKYA
3543
DELISTED
Akoya BioSciences
AKYA
| $88.5K | ﹤0.01% |
+7,532
| New | +$99.2K |
|
3544
Colliers International
CIGI
$5.37B
| $88.3K | ﹤0.01% |
963
-6,192
| -87% | -$722K |
|
3545
Palladyne AI
PDYN
$324M
| $88.3K | ﹤0.01% |
+6,626
| New | +$124K |
|
3546
Chunghwa Telecom
CHT
$33B
| $87.9K | ﹤0.01% |
2,475
+832
| +51% | +$33.1K |
|
3547
Ultrapar
UGP
$6.55B
| $86.6K | ﹤0.01% |
39,538
+1,355
| +4% | +$3.4K |
|
3548
DHI Group
DHX
$171M
| $86.5K | ﹤0.01% |
16,081
-13,164
| -45% | -$68.9K |
|
3549
Cenntro
CENN
$8.48M
| $85.7K | ﹤0.01% |
+139
| New | +$119K |
|
|
VLD
3550
DELISTED
Velo3D, Inc.
VLD
| $85.3K | ﹤0.01% |
+619
| New | +$80.4K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2022 Portfolio in Review
As of Q3 2022, BNP Paribas Financial Markets held 5,152 positions worth $62.5B, down 2.4% from $64.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
BNP Paribas Financial Markets deployed $254B of net new capital in Q3 2022, opening 1,204 new positions and adding to 1,887 existing holdings. Its largest new stake was Marvell Technology: 910,010 shares worth $39M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $622M trimmed.
- BNP Paribas Financial Markets's largest Q3 2022 buy was Marvell Technology: 910,010 shares worth $39M.
- BNP Paribas Financial Markets added most to Berkshire Hathaway Class A in Q3 2022, an estimated $255B increase.
- BNP Paribas Financial Markets's biggest Q3 2022 reduction was Apple, cutting an estimated $622M.
- BNP Paribas Financial Markets fully exited Alphabet (Google) Class A in Q3 2022, selling an estimated $533M.
- BNP Paribas Financial Markets's ten largest holdings make up 12% of its $62.5B portfolio in Q3 2022.
- BNP Paribas Financial Markets opened 1,204 new positions and closed 420 in Q3 2022.
- BNP Paribas Financial Markets's portfolio value fell 2.4% quarter-over-quarter to $62.5B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.